Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia
- 1 June 1999
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 55 (6) , 2477-2486
- https://doi.org/10.1046/j.1523-1755.1999.00479.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Is zinc protoporphyrin an indicator of iron-deficient erythropoiesis in maintenance haemodialysis patients?Nephrology Dialysis Transplantation, 1996
- Treatment of erythropoietin‐resistant anaemia with desferrioxamine in patients on haemofiltrationEuropean Journal of Haematology, 1995
- Foods Predictive of Nutrient Intake in Chinese Diet in Taiwan: II. Vitamin A, Vitamin B1, Vitamin B2, Vitamin C and CalciumInternational Journal of Epidemiology, 1992
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- IMPROVEMENT IN THE ERYTHROPOIESIS OF CHRONIC HAEMODIALYSIS PATIENTS WITH DESFERRIOXAMINEThe Lancet, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Serum Ascorbic Acid in Patients Undergoing Chronic HemodialysisActa Medica Scandinavica, 1983
- Hepatic hemosiderosis in maintenance hemodialysis (MHD) patientsDigestive Diseases and Sciences, 1980
- The diagnosis of iron deficiency anemiaThe American Journal of Medicine, 1964
- Siderosis in the BantuBMJ, 1962